1) malignant ovarian tumors
恶性卵巢肿瘤
1.
The malignant ovarian tumors have threatened the women’s health and lives severely.
恶性卵巢肿瘤严重威胁着妇女健康和生命,其重要原因之一是易发生淋巴转移,给临床诊断和治疗带来困难。
2) Ovarian cancer
卵巢恶性肿瘤
1.
Association of plasma level of urokinase-type plasminogen activator,urokinase-type plasminogen activator receptor (uPAR),and plasminogen activator inhibitors type 1 with ovarian cancer;
uPA、uPAR、PAI-1血浆含量与卵巢恶性肿瘤的相关性研究
2.
Clinical investigation of recurrent ovarian cancer;
复发性卵巢恶性肿瘤的临床分析
3.
Aim To study the treatment and management of ovarian cancers during pregnancy.
目的探讨妊娠合并卵巢恶性肿瘤的诊断和处理。
3) Ovarian malignancy
卵巢恶性肿瘤
1.
Expression of bcl-2 gene on multidrug resistance of ovarian malignancy;
bcl-2基因的表达在卵巢恶性肿瘤多药耐药中的意义
2.
Purpose: To estimate the value of multislice spiral CT(MSCT) in the preoperative staging of ovarian malignancy.
目的:评价多层螺旋CT对卵巢恶性肿瘤术前分期的价值。
5) ovarian carcinoma
卵巢恶性肿瘤
1.
Clinical significance of blood platelet count and serum fibrinogen in patients with ovarian carcinoma;
卵巢恶性肿瘤患者血浆纤维蛋白原及血小板四项参数检测的临床意义
2.
Objective: To select the ovarian carcinoma cell lines with high frequent metastasis and study the association between nm23-H1 gene expression and metastasis of ovarian carcinoma.
目的 筛选高频转移卵巢恶性肿瘤细胞，研究不同转移潜能的细胞和nm23的相关性。
3.
Objective:To investigate the expression of ApoaⅡ gene in ovarian carcinoma cells and different ovarian tissue,and explore its clinical significance in human ovarian cancer.
目的:探讨载脂蛋白AⅡ(ApoaⅡ)基因在卵巢恶性肿瘤组织中的表达及其临床意义。
6) Ovarian malignant tumor
卵巢恶性肿瘤
1.
Development in ultrasonic diagnosis of ovarian malignant tumors;
卵巢恶性肿瘤的超声诊断进展
2.
The molecular biological influences of hypoxia-inducible transcription factor-1 on ovarian malignant tumors;
缺氧诱导因子-1对卵巢恶性肿瘤的影响
3.
Preserving fertility treatment for 40 patients with ovarian malignant tumors;
对40例卵巢恶性肿瘤患者保留生育机能的治疗
补充资料：卵巢恶性勃伦那瘤
卵巢恶性勃伦那瘤
单侧或双侧发生，体积较大，平均直径14cm。切面实性，伴有大小不等囊腔，内有黏液或血性液体，或可见乳头、出血坏死。不少肿瘤伴有浆液性癌或宫内膜样癌。平均年龄在60岁以上，常见阴道出血、腹胀、腹痛、偶有腹水。按临床分期决定手术范围，术后是否辅以化疗或放疗尚有争议，预后很差。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条